HK-listed CStone Pharma jumps most in 6 wks on benchmark index inclusion

CStone Pharmaceuticals

23/08/2021 06:39

** Shares of cancer drug focused CStone Pharmaceuticals
 2616.HK  jump 9.3% to HK$12.74, the biggest daily percentage
gain since July 12, on track to snap four consecutive sessions
of decline
    ** Shanghai-based immuno-oncology medicines developer says
it will be included as a constituent stock of Hang Seng
Composite Index  .HSCI  effective Sept. 6  urn:newsml:reuters.com:*:nFWN2PR0JK
    ** Says the inclusion to the index indicates its stocks are
eligible for trading via the Hong Kong Stock Connect, while it
will help facilitate expansion of shareholder base and increase
the trading liquidity of the shares
    ** Hong Kong's healthcare index  .HSCIH  jumps 5% and the
Hang Seng Composite Index  .HSCI  rises 2.1%
    ** The Hang Seng China Enterprises Index  .HSCE  climbs
1.6%, and the benchmark index  .HSI  gains 1.7%
    ** As of last close, the stock had surged 15.7% this year

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))